Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$138M |
| 2 |
Alibaba
BABA
|
+$100M |
| 3 |
Microsoft
MSFT
|
+$72.8M |
| 4 |
Amazon
AMZN
|
+$65.7M |
| 5 |
Fox Class A
FOXA
|
+$46.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$165M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$68.3M |
| 3 |
Oracle
ORCL
|
+$43.1M |
| 4 |
PG&E
PCG
|
+$41.2M |
| 5 |
Qualcomm
QCOM
|
+$28.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 15.18% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Communication Services | 10.12% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Standard Motor Products
SMP
$870M
| $1.81M | ﹤0.01% |
36,800
+1,100
| +3% | +$54.3K |
|
|
WIFI
1727
DELISTED
Boingo Wireless, Inc.
WIFI
| $1.8M | ﹤0.01% |
77,450
+2,700
| +4% | +$61.4K |
|
|
UHT
1728
Universal Health Realty Income Trust
UHT
$573M
| $1.8M | ﹤0.01% |
23,800
+700
| +3% | +$49.9K |
|
|
FSCT
1729
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $1.8M | ﹤0.01% |
43,000
+2,300
| +6% | +$82.5K |
|
1730
TherapeuticsMD
TXMD
$24.1M
| $1.8M | ﹤0.01% |
7,370
+350
| +5% | +$92.6K |
|
1731
Angi Inc
ANGI
$196M
| $1.79M | ﹤0.01% |
11,600
+4,070
| +54% | +$659K |
|
|
ANAT
1732
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.78M | ﹤0.01% |
14,713
+500
| +4% | +$68.7K |
|
1733
Kadant
KAI
$3.91B
| $1.78M | ﹤0.01% |
20,200
+600
| +3% | +$51.6K |
|
|
LMNX
1734
DELISTED
Luminex Corp
LMNX
| $1.78M | ﹤0.01% |
77,200
+2,300
| +3% | +$57.7K |
|
|
SGMO
1735
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.77M | ﹤0.01% |
186,060
+6,300
| +4% | +$64.3K |
|
1736
Central Garden & Pet Co Class A
CENTA
$2.41B
| $1.77M | ﹤0.01% |
95,250
+4,125
| +5% | +$99.1K |
|
|
MTSC
1737
DELISTED
MTS Systems Corp
MTSC
| $1.77M | ﹤0.01% |
32,500
+1,200
| +4% | +$60.9K |
|
1738
Cushman & Wakefield Ltd
CWK
$3.37B
| $1.77M | ﹤0.01% |
99,400
+4,000
| +4% | +$68.9K |
|
1739
Artivion
AORT
$1.39B
| $1.77M | ﹤0.01% |
60,600
+2,100
| +4% | +$59.9K |
|
|
ESPR
1740
DELISTED
Esperion Therapeutics
ESPR
| $1.77M | ﹤0.01% |
44,000
+1,300
| +3% | +$58.3K |
|
1741
Champion Homes
SKY
$5.23B
| $1.77M | ﹤0.01% |
93,000
+33,000
| +55% | +$605K |
|
1742
Pacific Biosciences
PACB
$357M
| $1.77M | ﹤0.01% |
244,246
+11,800
| +5% | +$85.3K |
|
1743
Oil States International
OIS
$526M
| $1.76M | ﹤0.01% |
103,900
+3,100
| +3% | +$52.4K |
|
1744
Constellium
CSTM
$3.95B
| $1.76M | ﹤0.01% |
220,700
+6,600
| +3% | +$56.4K |
|
1745
Vanda Pharmaceuticals
VNDA
$304M
| $1.76M | ﹤0.01% |
95,500
+2,900
| +3% | +$66.1K |
|
|
RPT
1746
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.75M | ﹤0.01% |
146,100
+4,400
| +3% | +$54.7K |
|
1747
Madrigal Pharmaceuticals
MDGL
$11.7B
| $1.75M | ﹤0.01% |
14,000
+400
| +3% | +$49.7K |
|
1748
Independence Realty Trust
IRT
$4.01B
| $1.75M | ﹤0.01% |
162,000
+8,800
| +6% | +$90.5K |
|
|
TBI
1749
Trueblue
TBI
$309M
| $1.75M | ﹤0.01% |
73,800
+2,000
| +3% | +$46.7K |
|
|
TGI
1750
DELISTED
Triumph Group
TGI
| $1.73M | ﹤0.01% |
90,800
+2,700
| +3% | +$50.9K |
|
Similar funds
Swiss National Bank's Q1 2019 Portfolio in Review
As of Q1 2019, Swiss National Bank held 2,549 positions worth $91.2B, up 17% from $78B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 2.2%. Swiss National Bank opened 13 new positions and exited 42, leaving the 2,549-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2019 buy was Fox Class A: 1,197,967 shares worth $44M.
- Swiss National Bank added most to Walt Disney in Q1 2019, an estimated $138M increase.
- Swiss National Bank's biggest Q1 2019 reduction was Oracle, cutting an estimated $43.1M.
- Swiss National Bank fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $165M.
- Swiss National Bank's ten largest holdings make up 18% of its $91.2B portfolio in Q1 2019.
- Swiss National Bank opened 13 new positions and closed 42 in Q1 2019.
- Swiss National Bank's portfolio value rose 17% quarter-over-quarter to $91.2B.
Based on Swiss National Bank's 13F filing for Q1 2019, filed 10 May 2019.